Accepted for/Published in: JMIR Research Protocols
Date Submitted: Mar 23, 2020
Date Accepted: Aug 11, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Repetitive Transcranial Magnetic Stimulation (rTMS) with and without Internet-Delivered Cognitive Behavior Therapy (iCBT) For the Treatment of Resistant Depression (TRD): Protocol for patient-centred Randomized Controlled Pilot Trial
ABSTRACT
Background:
Major depression is a severe, disabling, and potentially lethal clinical disorder. only about half of the patients respond to an initial course of antidepressant pharmacotherapy. At least 15% of all patients with major depressive disorder remain refractory to any treatment intervention. By the time that a patient had experienced 3 definitive treatment failures, the likelihood of achieving remission with the fourth treatment option offered fell below 10%. These facts underline the clinical urgency for physicians to identify treatment-resistant patients as early as possible so that alternative treatments with proven efficacies may be offered sooner.
Objective:
This study will evaluate the initial comparative clinical effectiveness of repetitive Transcranial Magnetic Stimulation (rTMS) with and without Internet Delivered Cognitive Behavior Therapy (iCBT) as an innovative patient-centred intervention for the treatment of participants diagnosed with treatment-resistant depression (TRD).
Methods:
This study is a prospective, two-arm randomized controlled trial. 100 participants diagnosed with resistant depression in psychiatric care clinic in Edmonton, Alberta, Canada will be randomized to one of two conditions: (1) enrolment in rTMS sessions alone (2) enrolment in the rTMS sessions plus iCBT. Participants in each group will complete evaluation measures (e.g., recovery, general symptomatology and functional outcomes) at baseline, 1 month, 3 months and 6 months. The primary outcome measure would be the mean changed to scores on the Hamilton Depression Rating Scale. Patient service utilization data and clinician-rated measures will also be used to gauge patient progress. Patient data will be analyzed with descriptive statistics, repeated measures and correlational analyses.
Results:
We hypothesize that participants enrolled in the study who will receive rTMS plus iCBT will achieve superior outcomes in comparison to participants who receive rTMS alone.
Conclusions:
The concomitant application of psychotherapy with rTMS has not been investigated previously. We hope that this project will provide us with a concrete base of data to evaluate the practical application and efficacy of using a novel combination of these two treatment modalities (rTMS plus iCBT). Clinical Trial: Trial registration number on ClinicalTrials.gov: NCT04239651
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.